1. Clinical Overview
A fixed-dose combination of two osmotic agents, Glycerin and Mannitol, used primarily for the management of cerebral edema and elevated intracranial pressure (ICP). Glycerin is a trihydric alcohol and Mannitol is a sugar alcohol. Together, they create a synergistic osmotic effect, drawing fluid from the brain and eye into the vascular compartment, thereby reducing tissue pressure. This combination is particularly relevant in the Indian context for cost-effective neurocritical care and ophthalmic procedures.
| Onset | Duration | Bioavailability |
|---|---|---|
| Intravenous Mannitol: 15-30 minutes for reduction of intracranial pressure. Oral Glycerin: 10-30 minutes for reduction of intraocular pressure. | Mannitol: 3-8 hours for ICP reduction. Glycerin: 4-5 hours for IOP reduction. | Mannitol (IV): ~100%. Glycerin (Oral): ~80%. |
2. Mechanism of Action
Both agents are pharmacologically inert but osmotically active. When administered, they increase the osmolarity of plasma, creating an osmotic gradient between plasma and tissues (brain, eye). This draws water from the extracellular space of these tissues into the intravascular compartment, reducing tissue volume and pressure. Mannitol, when given IV, also induces an osmotic diuresis by preventing tubular reabsorption of water, further reducing total body water.
3. Indications & Uses
- Management of cerebral edema and elevated intracranial pressure (e.g., post-traumatic, post-stroke, peri-tumor)
- Reduction of intraocular pressure (IOP) in acute angle-closure glaucoma and prior to ophthalmic surgery
- Promotion of diuresis in the prevention/treatment of oliguric renal failure (post-crush injury, hemolytic transfusion reactions)
4. Dosage & Administration
Adult Dosage: Cerebral Edema/ICP: Mannitol IV: 0.25-1.5 g/kg as a 15-25% solution over 30-60 minutes. Often combined with Glycerin oral: 1-2 g/kg/day in divided doses (e.g., 10-20 gm every 4-6 hours). Acute Glaucoma: Glycerin oral: 1-1.5 g/kg as a single dose, often with Mannitol IV: 1.5-2 g/kg.
Administration: Mannitol: Administer IV via a large-bore vein using a filter (for concentrations >15%) to prevent crystallization. Infuse over 30-60 minutes. Glycerin: Administer orally, may be mixed with chilled juice to improve palatability and reduce nausea. Patient should be in a semi-recumbent position.
5. Side Effects
Common side effects may include:
- Headache
- Nausea, vomiting (especially with oral Glycerin)
- Dry mouth, thirst
- Diuresis, urinary urgency
- Transient hypotension or hypertension
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Other Diuretics (Furosemide, Thiazides) | Additive diuresis and electrolyte depletion (hypokalemia, hyponatremia). | Major |
| Nephrotoxic drugs (Aminoglycosides, Amphotericin B, Cisplatin) | Increased risk of acute renal failure. | Major |
| Digoxin | Hypokalemia potentiates digoxin toxicity. | Major |
| Lithium | Increased renal excretion of lithium, reducing its efficacy. | Moderate |
| Antihypertensives | Additive hypotensive effect. | Moderate |
7. Patient Counselling
- DO take Glycerin oral solution exactly as directed, often mixed with cold juice.
- DO report severe headache, confusion, excessive thirst, or reduced urination immediately.
- DO maintain adequate fluid intake as advised by your doctor to prevent dehydration.
- DONT drive or operate heavy machinery if feeling dizzy or having blurred vision.
- DONT use if you have severe kidney problems or are unable to urinate.
8. Toxicology & Storage
Overdose: Severe dehydration, hypernatremia, hyperosmolar coma, acute renal failure, pulmonary edema, circulatory collapse, metabolic acidosis (Glycerin).
Storage: Store Mannitol injection at room temperature (15-30°C). Protect from freezing. Solutions may crystallize at low temperatures; warm to redissolve before use. Store Glycerin oral solution in a cool, dry place, tightly closed. Keep away from direct sunlight and heat. Keep out of reach of children.